Delivery Order SPE2DB22D2005-SPE2DB25FJSR0
- Not listed
- The Defense Logistics Agency awarded a $1,113.80 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL) on June 5, 2025, with an ultimate completion date of June 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.64 to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML vials (10 ml) on September 10, 2025, with completion scheduled for September 11, 2025. This competitive award with firm fixed pricing represents a small-value pharmaceutical procurement utilizing no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Humalog 100 Unit/mL vial 10mL insulin medication. The contract is valued at $4,766.40 with a firm fixed price structure and an ultimate completion date of September 22, 2025. This delivery order was competitively awarded without set-aside designation and represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- This delivery order, valued at $1,025.32, awards AmerisourceBergen Drug Corp the supply of Humalog 100 Unit/mL vials (10 mL) for the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.39, is for the delivery of Humalog 100 unit/mL vial, 10 mL. The contract is a firm fixed price type and has a completion date of June 7, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency awarded a $1,253.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562194101 Humalog 100 unit/ml vials in quantities of 10ml each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. As the DLA supports the medical supply needs of the Department of Defense, this delivery order for insulin appears to be...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSR0Delivery Order
The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products, medical supplies, vaccines, and medical devices to military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains. The Humalog insulin product being delivered under this order supports the Defense Health Agency and other government healthcare systems' requirements for diabetes management medications, consistent with AmerisourceBergen's established role as a primary pharmaceutical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/26/25 |